Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1976 Aug;10(2):253–257. doi: 10.1128/aac.10.2.253

In Vitro Susceptibility of Common Clinical Anaerobic and Aerobic Isolates Against Josamycin

Richard E Reese 1, Robert F Betts 1, Lola W Goedde 1, R Gordon Douglas Jr 1
PMCID: PMC429731  PMID: 984766

Abstract

The in vitro susceptibility of 145 anaerobic clinical isolates and 96 gram-positive aerobic clinical isolates to josamycin, a new macrolide antibiotic, was studied using the agar dilution technique. Ninety-five of the aerobes were susceptible to 1.56 μg or less of josamycin per ml. The median minimal inhibitory concentration of these organisms was ≤0.39 μg/ml. The in vitro activity of josamycin against the anaerobes was compared with that of erythromycin, clindamycin, penicillin, and chloramphenicol. At concentrations ≤3.12 μg/ml, 100% of strains of Bacteroides species and Bacteroides fragilis were susceptible to josamycin. At low concentrations (≤0.39 μg/ml), clindamycin was more active than josamycin against the anaerobes. However, at concentrations ≤3.12 μg/ml, the activities of josamycin and clindamycin were similar except against the Fusobacterium species, which was quite resistant to josamycin.

Full text

PDF
253

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Finegold S. M., Bartlett J. G., Chow A. W., Flora D. J., Gorbach S. L., Harder E. J., Tally F. P. Management of anaerobic infections. Ann Intern Med. 1975 Sep;83(3):375–389. doi: 10.7326/0003-4819-83-3-375. [DOI] [PubMed] [Google Scholar]
  2. Frankel R. I. Clindamycin--efficacy and toxicity. West J Med. 1975 Jun;122(6):526–530. [PMC free article] [PubMed] [Google Scholar]
  3. Gorbach S. L., Bartlett J. G. Anaerobic infections. 1. N Engl J Med. 1974 May 23;290(21):1177–1184. doi: 10.1056/NEJM197405232902106. [DOI] [PubMed] [Google Scholar]
  4. Keeffe E. B., Katon R. M., Chan T. T., Melnyk C. S., Benson J. A., Jr Pseudomembranous enterocolitis. Resurgence related to newer antibiotic therapy. West J Med. 1974 Dec;121(6):462–472. [PMC free article] [PubMed] [Google Scholar]
  5. Marr J. J., Sans M. D., Tedesco F. J. Bacterial studies of Clindamycin-associated colitis. A preliminary report. Gastroenterology. 1975 Aug;69(2):352–358. [PubMed] [Google Scholar]
  6. Strausbaugh L. J., Dilworth J. A., Gwaltney J. M., Jr, Sande M. A. In vitro susceptibility studies with josamycin and erythromycin. Antimicrob Agents Chemother. 1976 Mar;9(3):546–548. doi: 10.1128/aac.9.3.546. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Tedesco F. J., Barton R. W., Alpers D. H. Clindamycin-associated colitis. A prospective study. Ann Intern Med. 1974 Oct;81(4):429–433. doi: 10.7326/0003-4819-81-4-429. [DOI] [PubMed] [Google Scholar]
  8. Yunis A. A. Chloramphenicol-induced bone marrow suppression. Semin Hematol. 1973 Jul;10(3):225–234. [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES